The alarmin IL33 orchestrates type 2 immune-mediated control of thymus regeneration

Nat Commun. 2023 Nov 8;14(1):7201. doi: 10.1038/s41467-023-43072-x.

Abstract

As the primary site of T-cell development, the thymus dictates immune competency of the host. The rates of thymus function are not constant, and thymus regeneration is essential to restore new T-cell production following tissue damage from environmental factors and therapeutic interventions. Here, we show the alarmin interleukin (IL) 33 is a product of Sca1+ thymic mesenchyme both necessary and sufficient for thymus regeneration via a type 2 innate immune network. IL33 stimulates expansion of IL5-producing type 2 innate lymphoid cells (ILC2), which triggers a cellular switch in the intrathymic availability of IL4. This enables eosinophil production of IL4 to re-establish thymic mesenchyme prior to recovery of thymopoiesis-inducing epithelial compartments. Collectively, we identify a positive feedback mechanism of type 2 innate immunity that regulates the recovery of thymus function following tissue injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alarmins*
  • Immunity, Innate
  • Interleukin-33*
  • Interleukin-4
  • Lymphocytes

Substances

  • Interleukin-33
  • Alarmins
  • Interleukin-4